SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
DNDPF DUNDEE CORPORATION 1ST PRF SHS SER 3
- 14.500
- 0.0000.00%
15min DelayClose Sep 17 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open14.500Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares14.07852wk High0.00P/B0Float Cap13.67852wk Low--Dividend TTM0Shs Float14.078Historical High--Div YieldTTM0.00%Amplitude13.678Historical Low--Avg Price1Lot Size
DUNDEE CORPORATION 1ST PRF SHS SER 3 Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.85%1.23M | -11.96%913K | -21.52%6.79M | -51.16%1.45M | 81.69%2.84M | -9.52%1.46M | -58.50%1.04M | -25.38%8.65M | 190.02%2.98M | -67.28%1.56M |
| Operating revenue | -15.85%1.23M | -11.96%913K | -21.52%6.79M | -51.16%1.45M | 81.69%2.84M | -9.52%1.46M | -58.50%1.04M | -25.38%8.65M | 190.02%2.98M | -67.28%1.56M |
| Cost of revenue | -55.79%363K | -24.44%637K | -36.23%1.96M | -147.96%-365K | 35.67%871K | -8.06%821K | 8.63%843K | -9.25%3.07M | 118.44%761K | -74.32%642K |
| Gross profit | 35.15%869K | 42.27%276K | -13.42%4.83M | -17.89%1.82M | 113.80%1.97M | -11.31%643K | -88.74%194K | -32.03%5.58M | 169.02%2.21M | -59.54%920K |
| Operating expense | 1.18%4.46M | -14.91%4.07M | -29.55%17.24M | -65.72%1.86M | -11.02%5.97M | -27.56%4.41M | -23.27%4.78M | -4.29%24.47M | -10.54%5.44M | 3.44%6.71M |
| Selling and administrative expenses | 0.67%4.22M | -14.91%4.07M | -34.98%15.22M | -68.50%1.62M | -28.63%4.62M | -28.51%4.2M | -19.15%4.78M | -1.80%23.41M | -21.89%5.15M | 10.03%6.48M |
| -General and administrative expense | 0.67%4.22M | -14.91%4.07M | -34.98%15.22M | -68.50%1.62M | -28.63%4.62M | -28.51%4.2M | -19.15%4.78M | -1.80%23.41M | -21.89%5.15M | 10.03%6.48M |
| Depreciation amortization depletion | 11.32%236K | ---- | 90.38%2.02M | -15.97%242K | 466.11%1.35M | -1.85%212K | ---- | -38.73%1.06M | 156.03%288K | -60.56%239K |
| -Depreciation and amortization | 11.32%236K | ---- | 90.38%2.02M | -15.97%242K | 466.11%1.35M | -1.85%212K | ---- | -38.73%1.06M | 156.03%288K | -60.56%239K |
| Operating profit | 4.62%-3.59M | 17.33%-3.79M | 34.31%-12.41M | 98.57%-46K | 30.84%-4.01M | 29.76%-3.77M | -1.75%-4.59M | -8.83%-18.89M | 38.66%-3.22M | -37.40%-5.79M |
| Net non-operating interest income expense | -4,010.00%-411K | -950.00%-391K | -21.93%1.09M | 755.42%1.09M | -252.00%-38K | -155.56%-10K | -96.96%46K | 9.01%1.39M | -147.70%-166K | -97.51%25K |
| Non-operating interest income | -5.85%193K | -27.55%192K | -21.46%1.9M | 679.87%1.24M | -18.53%189K | -18.65%205K | -85.07%265K | -23.77%2.42M | -65.73%159K | -85.33%232K |
| Non-operating interest expense | 180.93%604K | 166.21%583K | -20.84%813K | -53.23%152K | 9.66%227K | -8.12%215K | -16.09%219K | -45.83%1.03M | 180.17%325K | -64.00%207K |
| Other net income (expense) | 592.27%57.2M | 222.11%11.84M | -155.56%-28.96M | -111.13%-4.14M | -207.83%-23.39M | 116.35%8.26M | -122.13%-9.7M | 171.65%52.12M | 1,358.65%37.17M | 148.62%21.69M |
| Gain on sale of security | 360.62%45.32M | 257.26%12.27M | -147.37%-24.67M | -104.24%-1.68M | -221.18%-25.03M | 118.63%9.84M | -117.47%-7.8M | 168.40%52.08M | 730.48%39.59M | 146.47%20.66M |
| Earnings from equity interest | 3.30%-1.52M | 77.53%-426K | -175.44%-3.23M | -16.83%855K | -159.30%-612K | -169.55%-1.58M | -4,021.74%-1.9M | 2.96%4.28M | -74.91%1.03M | 753.16%1.03M |
| Special income (charges) | --13.41M | ---- | 75.03%-1.06M | 4.05%-3.31M | --2.26M | --0 | ---- | -449.55%-4.24M | -347.99%-3.45M | --0 |
| -Less：Restructuring and merger&acquisition | ---- | ---- | -69.37%1.06M | ---- | ---- | ---- | ---- | --3.45M | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 1.56%783K | --0 | --0 |
| -Gain on sale of business | --13.41M | ---- | ---- | ---- | --2.26M | --0 | ---- | ---- | ---- | --0 |
| Income before tax | 1,085.38%53.2M | 153.77%7.66M | -216.33%-40.28M | -109.17%-3.1M | -272.33%-27.43M | 108.03%4.49M | -134.89%-14.24M | 138.98%34.62M | 529.69%33.78M | 133.29%15.92M |
| Income tax | -80.00%591K | 126.98%757K | -119.40%-1.09M | -101.56%-45K | -120.46%-1.2M | 124.32%2.96M | -131.01%-2.81M | 82.52%5.63M | 12.13%2.89M | 1,117.71%5.85M |
| Net income | 3,331.77%52.61M | 159.06%6.9M | -346.65%-39.43M | -111.98%-3.05M | -703.94%-26.24M | 103.42%1.53M | -137.73%-11.68M | 115.84%15.99M | 251.13%25.47M | 108.91%4.34M |
| Net income continuous Operations | 3,331.77%52.61M | 160.34%6.9M | -235.15%-39.18M | -109.88%-3.05M | -360.45%-26.24M | 103.51%1.53M | -136.00%-11.43M | 131.55%28.99M | 396.08%30.89M | 120.86%10.07M |
| Net income discontinuous operations | --0 | --0 | 98.09%-248K | --0 | --0 | --0 | 69.04%-248K | -44.64%-13.01M | 15.44%-5.43M | -1,178.79%-5.73M |
| Minority interest income | 9.74%-278K | 8.04%-286K | 44.73%-619K | 46.76%-263K | 225.84%263K | -25.20%-308K | -81.87%-311K | 85.79%-1.12M | 84.64%-494K | 62.61%-209K |
| Net income attributable to the parent company | 2,772.73%52.89M | 163.19%7.18M | -326.88%-38.81M | -110.74%-2.79M | -681.99%-26.5M | 104.13%1.84M | -136.52%-11.37M | 118.39%17.11M | 290.41%25.96M | 109.45%4.55M |
| Preferred stock dividends | -37.58%789K | -39.25%791K | 20.65%5.18M | 0.98%1.34M | 16.99%1.27M | 30.04%1.26M | 43.71%1.3M | 17.66%4.29M | 42.87%1.32M | 19.28%1.09M |
| Other preferred stock dividends | 0 | 98.17%-20K | -6.1M | -4.11M | 0 | -890K | -1.1M | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3,451.33%52.1M | 155.40%6.41M | -395.63%-37.89M | -100.04%-11K | -901.73%-27.77M | 103.22%1.47M | -138.30%-11.58M | 113.26%12.82M | 269.22%24.64M | 107.06%3.46M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |